16
Chikanza LC,Panayi GS (1993) The effects of hydrocortisone on in vitro lymphocyte pro-
liferation and interleukin-2 and -4 production in corticosteroid sensitive and resis-
tant subjects. Eur J Clin Invest 23, 845.
Collaziol D, Luz C, Dornelles F, da Cruz IM,Bauer ME (2004) Psychoneurodendocrine
correlates of lymphocyte subsets during healthy ageing. Mech Ageing Dev 125, 219.
Corkill MM, Kirkham BW, Chikanza IC, Gibson T,Panayi GS (1990) Intramuscular depot
methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24-week
randomized controlled trial. Br J Rheumatol 29, 274.
Croxtall JD, Choudhury Q,Flower RJ (2000) Glucocorticoids act within minutes to inhibit
recruitment of signalling factors to activated EGF receptors through a receptor-
dependent, transcription-independent mechanism. Br J Pharmacol 130, 289.
de Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E,Chrousos GP (1996) The
non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta):
tissue levels, mechanism of action, and potential physiologic role. Mol Med 2, 597.
Dean M, Hamon Y,Chimini G (2001) The human ATP-binding cassette (ABC) transporter
superfamily. J Lipid Res 42, 1007.
del Rincon I, O'Leary DH, Haas RW,Escalante A (2004) Effect of glucocorticoids on the
arteries in rheumatoid arthritis. Arthritis Rheum 50, 3813.
Dhabhar FS,McEwen BS (1999) Enhancing versus suppressive effects of stress hormones
on skin immune function. Proc Natl Acad Sci U S A 96, 1059.
Dieckmann D, Plottner H, Berchtold S, Berger T,Schuler G (2001) Ex vivo isolation and
characterization of CD4(+)CD25(+) T cells with regulatory properties from human
blood. J Exp Med 193, 1303.
Doran MF, Pond GR, Crowson CS, O'Fallon WM,Gabriel SE (2002) Trends in incidence
and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year pe-
riod. Arthritis Rheum 46, 625.
Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, Huber H,Andreeff M (1992) Sub-
populations of normal peripheral blood and bone marrow cells express a functional
multidrug resistant phenotype. Blood 80, 2729.
Drach J, Gsur A, Hamilton G, Zhao S, Angerler J, Fiegl M, Zojer N, Raderer M, Haberl I,
Andreeff M,Huber H (1996) Involvement of P-glycoprotein in the transmembrane
transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T
lymphocytes. Blood 88, 1747.
Encio IJ,Detera-Wadleigh SD (1991) The genomic structure of the human glucocorticoid
receptor. J Biol Chem 266, 7182.
Farrell RJ,Kelleher D (2003) Glucocorticoid resistance in inflammatory bowel disease. J
Endocrinol 178, 339.
Feldmann M, Brennan FM,Maini RN (1996) Rheumatoid arthritis. Cell 85, 307.
Fernandes G,Gupta S (1981) Natural killing and antibody-dependent cytotoxicity by lym-
phocyte subpopulations in young and aging humans. J Clin Immunol 1, 141.
Franchimont D, Martens H, Hagelstein MT, Louis E, Dewe W, Chrousos GP, Belaiche
J,Geenen V (1999) Tumor necrosis factor alpha decreases, and interleukin-10 in-
creases, the sensitivity of human monocytes to dexamethasone: potential regulation
of the glucocorticoid receptor. J Clin Endocrinol Metab 84, 2834.
Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, O'Shea JJ,
Chrousos GP,Bornstein SR (2002) Gene profiling reveals unknown enhancing and
suppressive actions of glucocorticoids on immune cells. Faseb J 16, 61.